Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of hmg coa reductase and ubiad1

Rania Elsabrouty, Youngah Jo, Seonghwan Hwang, Dong Jae Jun, Russell A. Debose-Boyd

Research output: Contribution to journalArticlepeer-review

Abstract

UbiA prenyltransferase domain-containing protein-1 (UBIAD1) utilizes geranylgeranyl pyrophosphate (GGpp) to synthesize the vitamin K2 subtype menaquinone-4. The prenyltransferase has emerged as a key regulator of sterol-accelerated, endoplasmic reticulum (ER)-associated degradation (ERAD) of HMG CoA reductase, the rate-limiting enzyme in synthesis of cholesterol and nonsterol isoprenoids including GGpp. Sterols induce binding of UBIAD1 to reductase, inhibiting its ERAD. Geranylgeraniol (GGOH), the alcohol derivative of GGpp, disrupts this binding and thereby stimulates ERAD of reductase and translocation of UBIAD1 to Golgi. We now show that overexpression of Type 1 polyisoprenoid diphosphate phosphatase (PDP1), which dephosphorylates GGpp and other isoprenyl pyrophosphates to corresponding isoprenols, abolishes protein geranylgeranylation as well as GGOH-induced ERAD of reductase and Golgi transport of UBIAD1. Conversely, these reactions are enhanced in the absence of PDP1. Our findings indicate PDP1-mediated hydrolysis of GGpp significantly contributes to a feedback mechanism that maintains optimal intracellular levels of the nonsterol isoprenoid.

Original languageEnglish (US)
Article numbere64688
JournaleLife
Volume10
DOIs
StatePublished - Nov 2021

Keywords

  • Cholesterol
  • Golgi
  • Isoprenoid
  • Prenylation
  • Pyrophosphate

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Fingerprint

Dive into the research topics of 'Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of hmg coa reductase and ubiad1'. Together they form a unique fingerprint.

Cite this